Nirvana Life Sciences Inc.
Nirvana Life Sciences Inc.
CSE Index:
Currency:
Nirvana Life Sciences Inc. is focused on developing medical products and regimens that address addiction. Nirvana is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency and other health problems.
Nirvana Life Sciences Inc. (NIRV)
SEDAR Information
Company Info
Address
Suite 2110, 650 West Georgia Street
Vancouver, BC V6B 4N8
CanadaPhone
(604) 401-8100Email
[email protected]Website
https://nirvanalifescience.comListing date
Thursday, March 17, 2022Transfer Agent
Computershare Investor Services Inc.Capitalization
Issued & Outstanding:
33020139Reserved for Issuance:
300000News Releases
10/10/2023
MCTO Update
Bulletins
20/12/2024
2024-1233 - Reinstatement - Nirvana Life Sciences Inc. (NIRV)
le 20 décembre/December 2024
Effective immediately, Nirvana Life Sciences Inc. will be reinstated for trading.
The Company has rectified the situation that gave rise to the suspension.
____________________________
Avec effet immédiat, Nirvana Life Sciences Inc. sera réintégrée à la négociation.
La Société a rectifié la situation qui a donné lieu à la suspension.
